Global Down Syndrome

Winter 2017

Issue link: https://viewer.e-digitaledition.com/i/802686

Contents of this Issue

Navigation

Page 10 of 31

SCIENCE SNPs METFORMIN — A POTENTIAL THERAPY FOR MISFIRING MITOCHONDRIA People with Down syndrome, or trisomy 21, frequently have abnormalities in mitochondria, cells' primary sources of energy. Those abnormalities are thought to contribute to many physical and mental health issues, including developmental delays, Alzheimer's disease, heart defects, and immune system disorders. Using tissue samples from fetuses with Down syndrome, a team of scientists from Italy and Sweden showed that the drug metformin boosted overall mitochondrial activity. Specifically, metformin activates the PGC-1α gene, which regulates the production of mitochondria. In trisomic cells, metformin reversed inhibition of PGC-1α, leading to downstream effects on other proteins and genes that regulate the energy status of cells and mitochondrial function and networks. Such alterations could potentially protect people with Down syndrome from a number of health conditions and improve overall quality of life, according to the authors. Human Molecular Genetics, JANUARY 2017 IGG2 DEFICIENCY: THE CAUSE OF TOO MANY INFECTIONS? School-age children with Down syndrome suffer from respiratory and ear infections more frequently than their typical peers. Researchers in the Department of Immunology at the Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorder, revealed that deficiencies in immunoglobulin G subclass 2 (IgG2), an antibody that protects against pneumococcal disease and Haemophilus influenzae bacteria, could be the cause of this discrepancy. Blood samples from 40 children with Down syndrome and 30 typical children showed that IgG2 levels in the former group were significantly lower than those of the latter. This discovery could lead to better management of bacterial infections for children with Down syndrome. IMC Journal of Medical Science, JANUARY 2017 LYCOPENE-RICH DIETS COULD LIMIT OXIDATIVE STRESS People with Down syndrome have low levels of the antioxidant lycopene, which is thought to protect neurons from oxidative stress. Korean researchers have found that lycopene inhibits cell death caused by overexpression of the RCAN1 gene, which is triplicated in people with Down syndrome and has been linked to neuronal impairment in these individuals. Using Down syndrome cell samples, the scientists learned that lycopene reduces RCAN1's effects on reactive oxygen species and inhibits Nucling induction and NF-kB activation, two molecular processes linked to cell death. They conclude that eating lycopene-rich foods, such as tomatoes and watermelon, could limit the neuronal damage caused by oxidative stress in people with Down syndrome. Molecular Nutrition & Food Research, DECEMBER 2016 GLOBALDOWNSYNDROME.ORG 11

Articles in this issue

Links on this page

Archives of this issue

view archives of Global Down Syndrome - Winter 2017